Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Previous revision
cl:psychiatric-side-effects-of-medications [on April 17, 2019]
cl:psychiatric-side-effects-of-medications [on April 30, 2020]
Line 1: Line 1:
 ====== Psychiatric Side Effects of Medications and Substances ====== ====== Psychiatric Side Effects of Medications and Substances ======
 +{{INLINETOC}}
 ===== Primer ===== ===== Primer =====
 Medications and recreational substances can have profound psychiatric symptoms for patients. Medications and recreational substances can have profound psychiatric symptoms for patients.
Line 6: Line 7:
   * [[https://​www.ncbi.nlm.nih.gov/​pmc/​articles/​PMC3181628/​|Tango,​ R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience,​ 5(2), 155.]]   * [[https://​www.ncbi.nlm.nih.gov/​pmc/​articles/​PMC3181628/​|Tango,​ R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience,​ 5(2), 155.]]
   * [[https://​jamanetwork.com/​journals/​jama/​fullarticle/​2684607|Qato,​ D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]]   * [[https://​jamanetwork.com/​journals/​jama/​fullarticle/​2684607|Qato,​ D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]]
 +
 +
 +===== Substance/​Medication-Induced Major or Mild Neurocognitive Disorder =====
 +<WRAP group>
 +<WRAP half column>
 +== Criterion A ==
 +The criteria are met for major or mild neurocognitive disorder.
 +
 +== Criterion B ==
 +The neurocognitive impairments do not occur exclusively during the course of a delirium and persist beyond the usual duration of intoxication and acute withdrawal.
 +
 +== Criterion C ==
 +The involved substance or medication and duration and extent of use are capable of producing the neurocognitive impairment.
 +
 +== Criterion D ==
 +The temporal course of the neurocognitive deficits is consistent with the timing of substance or medication use and abstinence (e.g., the deficits remain stable or improve after a period of abstinence).
 +
 +</​WRAP>​
 +<WRAP half column>
 +== Criterion E ==
 +The neurocognitive disorder is not attributable to another medical condition or is not better explained by another mental disorder
 +
 +== Specifiers ==
 +<​accordion collapsed="​false">​
 +<panel icon="​fa fa-search-plus"​ size="​xs"​ title="​Substance Specifier">​
 +  * Alcohol (major neurocognitive disorder), nonamnestic-confabulatory type
 +  * Alcohol (major neurocognitive disorder), amnestic-confabulatory type
 +  * Alcohol (mild neurocognitive disorder)
 +  * Inhalant (major neurocognitive disorder)
 +  * Inhalant (mild neurocognitive disorder)
 +  * Sedative, hypnotic, or anxiolytic (major neurocognitive disorder)
 +  * Sedative, hypnotic, or anxiolytic (mild neurocognitive disorder)
 +  * Other (or unknown) substance (major neurocognitive disorder)
 +  * Other (or unknown) substance (mild neurocognitive disorder)
 +</​panel>​
 +<panel icon="​fa fa-search-plus"​ size="​xs"​ title="​Other Specifier">​
 +**Specify if:**
 +  * Persistent: neurocognitive impairment continues to be significant after an extended period of abstinence.
 +</​panel>​
 +</​accordion>​
 +</​WRAP>​
 +</​WRAP>​
 +